The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ALECTOR INC | COM | 014442107 | 2,040,810 | 339,569 | SH | DFND | 339,569 | 0 | 0 | ||
ARAVIVE INC | COM | 03890D108 | 1,192,493 | 946,423 | SH | DFND | 946,423 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 32,005,911 | 1,289,521 | SH | DFND | 1,289,521 | 0 | 0 | ||
COGENT BIOSCIENCES INC. | COM | 19240Q201 | 5,938,115 | 501,530 | SH | DFND | 501,530 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS INC | COM | 22663K107 | 2,540,820 | 141,000 | SH | DFND | 141,000 | 0 | 0 | ||
DECIPHERA PHARMACEUTICALS INC | COM | 24344T101 | 17,030,760 | 1,209,571 | SH | DFND | 1,209,571 | 0 | 0 | ||
DICE THERAPEUTICS INC | COM | 23345J104 | 17,268,857 | 371,693 | SH | DFND | 371,693 | 0 | 0 | ||
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 12,040,873 | 1,553,661 | SH | DFND | 1,553,661 | 0 | 0 | ||
HARPOON THERAPEUTICS INC | COM | 41358P106 | 2,241,256 | 3,156,699 | SH | DFND | 3,156,699 | 0 | 0 | ||
ITERUM THERAPEUTICS PLC | SHS | G6333L200 | 103,880 | 97,084 | SH | DFND | 97,084 | 0 | 0 | ||
PASSAGE BIO | COM | 702712100 | 2,348,047 | 2,497,922 | SH | DFND | 2,497,922 | 0 | 0 | ||
RALLYBIO CORPORATION | COM | 75120L100 | 18,687,073 | 3,301,603 | SH | DFND | 3,301,603 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 2,349,469 | 118,242 | SH | DFND | 118,242 | 0 | 0 | ||
X4 PHARMACEUTICALS INC | COM | 98420X103 | 649,900 | 335,000 | SH | DFND | 335,000 | 0 | 0 |